Brucellosis is an old disease, revisited because of its past use in biological warfare programs and its potential use in bioterrorism. Early recognition and management of this systemic disease in its acute or chronic form is vital to current antibioterrorism defense programs. This article focuses on the causative organism, as well as the clinical presentation, diagnosis, and therapeutic challenges of Brucellosis.